Cargando…
Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
Several data indicate that migraine, especially migraine with aura, is associated with an increased risk of ischemic stroke and other vascular events. Of concern is whether the risk of ischemic stroke in migraineurs is magnified by the use of hormonal contraceptives. As migraine prevalence is high i...
Autores principales: | Sacco, Simona, Merki-Feld, Gabriele S., Ægidius, Karen Lehrmann, Bitzer, Johannes, Canonico, Marianne, Kurth, Tobias, Lampl, Christian, Lidegaard, Øjvind, Anne MacGregor, E., MaassenVanDenBrink, Antoinette, Mitsikostas, Dimos-Dimitrios, Nappi, Rossella Elena, Ntaios, George, Sandset, Per Morten, Martelletti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662520/ https://www.ncbi.nlm.nih.gov/pubmed/29086160 http://dx.doi.org/10.1186/s10194-017-0815-1 |
Ejemplares similares
-
Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2018) -
Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
por: Sacco, Simona, et al.
Publicado: (2018) -
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022) -
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018) -
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)